Endothelial Function in Prehypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the frame of this proposal investigators will test the hypothesis that high normal blood pressure (prehypertension; PreHT) induces systemic endothelial dysfunction and endothelial activation in both micro- and macrocirculation, reduces re-endothelialization potential of human endothelial progenitor cells (EPCs) and increases the level of endothelial extracellular vesicles (EVs), which are accompanied by increased oxidative stress level. Furthermore, initial vascular and left ventricle (LV) remodeling contributes to changes in systemic hemodynamics and may be influenced by altered regulatory role of renin-angiotensin system (RAS) and autonomic nervous system (ANS) in PreHT but otherwise healthy individuals. To distinguish high normal blood pressure effect from those considered normal or high, study will be performed in three groups of individuals: prehypertensive (BP 130-139/85-89 mmHg), hypertensive (stage I, BP 140-150/90-100 mmHg), and controls (BP less than or equal to 129/85 mmHg). Altogether, the impairment of normal vascular relaxation mechanisms, endothelial activation as well as vascular and LV remodeling could play crucial role in increased cardiovascular risk and CVDs incidence in PreHT individuals. Moreover, the prognostic significance of assessing endotehlial dysfunction in hypertension (as well as in PreHT) is yet to be established.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dietary Salt and Microvascular Function

NCT02727426

Salt; Excess

UNKNOWN NA

Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients

NCT00689819

Hypertension High Blood Pressure Ventricular Hypertrophy +2 more

COMPLETED NA

Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure

NCT00925470

Blood Pressure

COMPLETED

Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients

NCT02616822

Endothelial Dysfunction

COMPLETED PHASE1

From Micro- to Macro-vessels : Water, Salt, Heart and Kidneys

NCT05114291

Hypertension

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension,Essential

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normotensive Group

BP less than or equal to 129/84 mmHg

No interventions assigned to this group

Prehypertensive Group

BP 130-139/85-89 mmHg

No interventions assigned to this group

Hypertensive Group

BP 140-150/90-100 mmHg

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults of both sexes with normotensive, prehypertensive and grade I hypertension blood pressure values

Exclusion Criteria

* cardiovascular diseases, but grade I hypertension (BP 140-150/90-100 mmHg)
* diabetes
* kidney disease
* cerebrovascular diseases
* peripheral artery disease
* taking oral contraceptives or any drugs that could affect the endothelium

Minimum Eligible Age

18 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes